Latest period
$6.49B
YoY change
+22.7%
5Y CAGR
+19.0%
Peak year (2025)
$5.97B
Latest annual
$5.97B
Total Equity history chart for ResMed (RMD) from 1993 to 2025
Latest: $5.97B
Total Equity growth chart for ResMed (RMD) from 1993 to 2025
Latest: +22.7%
Total Equity history table for ResMed (RMD) from 1993 to 2025
| 2025 | $5.97B | +22.7% | +$1.10B | ||
| 2024 | $4.86B | +17.8% | +$734.14M | ||
| 2023 | $4.13B | +22.9% | +$769.15M | ||
| 2022 | $3.36B | +16.5% | +$475.07M | ||
| 2021 | $2.89B | +15.6% | +$388.65M | ||
| 2020 | $2.50B | +20.5% | +$424.83M | ||
| 2019 | $2.07B | +0.6% | +$13.21M | ||
| 2018 | $2.06B | +5.0% | +$98.71M | ||
| 2017 | $1.96B | +15.7% | +$265.44M | ||
| 2016 | $1.69B | +6.8% | +$107.52M | ||
| 2015 | $1.59B | -9.7% | −$170.94M | ||
| 2014 | $1.76B | +9.2% | +$147.73M | ||
| 2013 | $1.61B | +0.2% | +$2.89M | ||
| 2012 | $1.61B | -7.1% | −$123.11M | ||
| 2011 | $1.73B | +34.4% | +$443.20M | ||
| 2010 | $1.29B | +15.5% | +$172.34M | ||
| 2009 | $1.12B | +3.1% | +$33.42M | ||
| 2008 | $1.08B | +16.2% | +$150.55M | ||
| 2007 | $931.22M | +26.2% | +$193.07M | ||
| 2006 | $738.15M | +55.7% | +$264.08M | ||
| 2005 | $474.06M | +31.1% | +$112.57M | ||
| 2004 | $361.50M | +26.2% | +$75.07M | ||
| 2003 | $286.43M | +48.5% | +$93.50M | ||
| 2002 | $192.93M | +92.2% | +$92.56M | ||
| 2001 | $100.37M | +6.8% | +$6.39M | ||
| 2000 | $93.97M | +31.2% | +$22.37M | ||
| 1999 | $71.60M | +40.9% | +$20.80M | ||
| 1998 | $50.80M | +13.9% | +$6.20M | ||
| 1997 | $44.60M | +14.4% | +$5.60M | ||
| 1996 | $39.00M | +34.9% | +$10.10M | ||
| 1995 | $28.90M | +416.1% | +$23.30M | ||
| 1994 | $5.60M | +93.1% | +$2.70M | ||
| 1993 | $2.90M | — | — |
- 2025$5.97B+22.7%
- 2024$4.86B+17.8%
- 2023$4.13B+22.9%
- 2022$3.36B+16.5%
- 2021$2.89B+15.6%
- 2020$2.50B+20.5%
- 2019$2.07B+0.6%
- 2018$2.06B+5.0%
- 2017$1.96B+15.7%
- 2016$1.69B+6.8%
- 2015$1.59B-9.7%
- 2014$1.76B+9.2%
- 2013$1.61B+0.2%
- 2012$1.61B-7.1%
- 2011$1.73B+34.4%
- 2010$1.29B+15.5%
- 2009$1.12B+3.1%
- 2008$1.08B+16.2%
- 2007$931.22M+26.2%
- 2006$738.15M+55.7%
- 2005$474.06M+31.1%
- 2004$361.50M+26.2%
- 2003$286.43M+48.5%
- 2002$192.93M+92.2%
- 2001$100.37M+6.8%
- 2000$93.97M+31.2%
- 1999$71.60M+40.9%
- 1998$50.80M+13.9%
- 1997$44.60M+14.4%
- 1996$39.00M+34.9%
- 1995$28.90M+416.1%
- 1994$5.60M+93.1%
- 1993$2.90M—
Total Equity values are taken from ResMed's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported total equity is $6.49B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total equity for ResMed (RMD) came in at $5.97B – grew 22.7% year-over-year.
ResMed total equity has grown for 10 consecutive years, with a +19.0% compound annual growth rate over 2020–2025 (5 years).
$5.97B stands as the all-time-high annual total equity, posted in 2025, against a low of $2.90M during 1993.
ResMed Total Equity by Year
ResMed Total Equity 2025: $5.97B
2025's total equity for ResMed came in at $5.97B, grew 22.7% from 2024. This figure represents the highest annual value in the available history.
ResMed Total Equity 2024: $4.86B
ResMed posted total equity of $4.86B in 2024, grew 17.8% from 2023.
ResMed Total Equity 2023: $4.13B
In 2023, ResMed reported total equity of $4.13B, grew 22.9% from 2022.
ResMed Total Equity 2022: $3.36B
ResMed total equity in 2022 was $3.36B, grew 16.5% from 2021.
ResMed Total Equity 2021: $2.89B
ResMed total equity in 2021 was $2.89B.
See more financial history for ResMed (RMD).
Sector peers by Total Equity
Healthcare peers of ResMed (RMD), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation